 |
hematopoietic stem cells modified with a lentiviral vector containing the CD18 (Integrin Beta 2) gene |
|---|---|
| Trade Name | Ladilen |
| Orphan Indication | Leukocyte adhesion deficiency Type I |
| USA Market Approval | USA |
| USA Designation Date | 2016-11-09 00:00:00 |
| Sponsor | Consorcio Centro de Investigaci�n Biom�dica en Red, M.P.;Montforte de Lemos, 3-5 Pabellon 11;Madrid |
